influenza
virus
among
import
human
pathogen
type
b
clinic
relev
human
type
sole
caus
pandem
influenza
sever
acut
highli
contagi
respiratori
system
diseas
symptom
includ
high
fever
chill
gener
weak
diffus
headach
runni
nose
muscl
ach
sore
throat
dri
paroxysm
cough
conjunct
estim
yearli
season
influenza
caus
million
sever
case
associ
death
influenza
virus
infect
wide
varieti
speci
current
two
strain
believ
circul
human
number
strain
resid
bird
mammal
sporad
transmiss
human
occur
frequent
character
high
pathogen
key
factor
make
influenza
viru
uniqu
variabl
genom
present
virion
eight
segment
coinfect
singl
cell
result
shuffl
genom
rna
puzzl
new
hybrid
progeni
emerg
reassort
usual
less
fit
elimin
sporad
case
new
strain
appear
abl
effect
infect
human
cell
recogn
defens
system
recommend
vaccin
effect
way
prevent
diseas
provid
protect
howev
vaccin
provid
complet
protect
especi
infant
elderli
patient
immun
deficit
antivir
therefor
complementari
tool
comprehens
manag
approv
antiinfluenza
drug
avail
old
gener
drug
amantadin
rimantadin
interfer
protein
activ
inhibit
releas
viral
genom
replic
site
viru
entri
unfortun
due
emerg
drugresist
variant
medicin
product
alreadi
withdrawn
second
group
drug
encompass
zanamivir
oseltamivir
inhibit
activ
neuraminidas
na
protein
na
inhibitor
nai
interfer
viru
egress
lesser
extent
also
entri
howev
emerg
drug
resist
alreadi
report
octob
fda
approv
new
antiinfluenza
activ
substanc
baloxavir
marboxil
xofluza
baloxavir
inhibit
viral
endonucleas
respons
cleavag
cellular
mrna
near
order
gener
primer
requir
viral
rna
synthesi
cap
snatch
nonetheless
clearli
shown
eg
viru
combin
therapi
simultan
interf
differ
molecular
target
effect
longlast
berberin
bbr
isoquinolin
alkaloid
belong
structur
class
protoberberin
produc
plant
includ
berberi
vulgari
copti
sp
bbr
long
histori
tradit
remedi
mani
part
world
activ
bbr
wide
discuss
scientif
report
exhibit
therapeut
properti
includ
antiinflammatori
antioxid
anticanc
anticonvuls
antidepress
antialzheim
antiarrhythm
antidiabet
effect
vitro
vivo
moreov
compound
exhibit
broadspectrum
antimicrobi
activ
bacteria
virus
bbr
report
effect
streptococcu
agalactia
actinobacillu
pleuropneumonia
staphylococcu
spp
addit
bbr
shown
block
herp
simplex
viru
type
replic
vero
cell
recent
studi
shown
potent
inhibit
zika
viru
zikv
report
shown
bbrmediat
suppress
respiratori
syncyti
viru
rsv
replic
epitheli
cell
probabl
via
inhibit
rsvmediat
earli
mitogenactiv
protein
kinas
mapk
activ
inhibit
viru
entri
cell
anoth
public
show
inhibitori
effect
chikungunya
viru
chikv
inhibit
virusinduc
mapk
signal
literatur
claim
bbr
also
inhibit
replic
influenza
viru
work
cecil
et
al
bbr
inhibit
replic
two
strain
viru
murin
macrophag
cell
line
raw
adenocarcinoma
human
alveolar
basal
epitheli
cell
prevent
express
viral
protein
author
report
viru
replic
diminish
induc
format
viral
protein
aggreg
within
host
cell
cytoplasm
vivo
experi
mice
model
confirm
observ
bbr
reduc
mice
mortal
decreas
viru
titer
lung
day
postinfect
pi
moreov
bbr
also
suppress
pulmonari
inflamm
reduc
necrosi
inflammatori
cell
infiltr
pulmonari
edema
cecil
et
al
test
antiinfluenza
properti
bbr
use
three
vitro
model
ie
cell
raw
cell
canin
kidney
mdck
cell
observ
inhibit
viru
replic
first
two
cell
type
inhibit
note
mdck
cell
hand
wu
et
al
test
bbr
mdck
cell
observ
strong
inhibit
viru
replic
despit
numer
report
bbr
activ
mechan
antivir
action
far
understood
result
show
strong
antiinfluenza
properti
bbr
vitro
ex
vivo
believ
observ
effect
relev
human
bodi
moreov
show
bbr
block
influenzainduc
mitogenactiv
protein
kinaseextracellular
signalrel
kinas
mapkerk
pathway
requir
transport
viral
ribonucleoprotein
cytoplasm
berberin
chlorid
hydrat
bbr
obtain
poznan
poland
stock
solut
bbr
mm
prepar
dissolv
bbr
dimethyl
sulfoxid
dmso
poznan
poland
fresh
stock
prepar
experi
stock
invivogen
toulous
franc
specif
inhibitor
extracellular
signalrel
kinas
erk
dissolv
dmso
mm
aliquot
store
canin
kidney
mdck
cell
atcc
cell
line
adenocarcinoma
human
alveolar
basal
epitheli
cell
atcc
cell
line
lung
epitheli
type
mous
immort
cell
line
bei
resourc
manassa
va
usa
maintain
dulbecco
modifi
eagl
medium
dmem
high
glucos
life
technolog
eugen
usa
supplement
heatinactiv
fetal
bovin
serum
fb
life
technolog
usa
penicillin
uml
streptomycin
dmem
cell
cultur
atmospher
contain
human
airway
tracheobronchi
epitheli
hae
cell
obtain
airway
specimen
resect
patient
undergo
surgeri
silesian
center
heart
diseas
studi
approv
bioethic
committe
medic
univers
silesia
katowic
poland
approv
date
februari
written
consent
obtain
patient
primari
cell
cultur
plastic
gener
passag
cell
plate
densiti
cellswel
permeabl
transwel
insert
support
hae
cultur
gener
provis
interfac
week
form
fulli
differenti
polar
cultur
resembl
pseudostratifi
mucociliari
epithelium
human
season
influenza
viru
type
strain
ahong
obtain
european
viru
archiv
eva
project
evag
marseil
franc
viru
stock
gener
infect
mdck
cell
confluenc
h
time
cultur
aliquot
store
mock
sampl
prepar
manner
use
uninfect
cell
viru
stock
quantifi
titrat
previous
describ
mdck
cell
seed
plate
tpp
trasadingen
switzerland
densiti
cell
per
well
h
cell
infect
influenza
viru
dose
tissu
cultur
infecti
dose
ml
presenc
bbr
total
volum
dmem
supplement
penicillinstreptomycin
tpcktreat
trypsin
poznan
poland
case
hae
cultur
viru
bbr
appli
apic
surfac
hae
cultur
control
sampl
inocul
manner
volum
mock
andor
dmso
h
incub
cell
rins
thrice
pb
fresh
medium
supplement
bbr
ad
infect
carri
h
cell
line
h
hae
viru
yield
measur
use
rtqpcr
method
describ
determin
whether
bbr
affect
particular
stage
replic
cycl
viru
seri
previous
describ
mechanist
experi
carri
assay
conduct
subconflu
cell
viru
inactiv
assay
show
influenc
test
compound
viral
particl
influenza
viru
stock
incub
bbr
constant
mix
h
room
temperatur
sampl
dilut
time
ensur
bbr
concentr
lower
limit
effect
rang
sampl
titrat
accord
reed
muench
method
ii
cell
protect
assay
examin
effect
compound
cell
surfac
assay
cell
incub
bbr
h
incub
media
remov
cell
wash
pb
cell
infect
influenza
viru
mock
control
h
next
media
discard
cell
wash
thrice
pb
fresh
infect
medium
ad
cell
incub
h
iii
viru
attach
assay
examin
effect
compound
interact
confluent
cell
precool
overlaid
icecold
influenza
viru
bbrcontain
medium
mock
control
sampl
incub
h
allow
viru
attach
host
cell
viru
intern
cell
rins
thrice
cold
pb
remov
residu
viru
fresh
medium
appli
cell
incub
h
iv
viru
intern
assay
evalu
viru
entri
suscept
cell
precool
confluent
cell
infect
viru
icecold
solut
h
avoid
viru
intern
cell
incub
medium
discard
cell
wash
thrice
cold
pb
media
supplement
bbr
appli
sampl
incub
h
allow
viru
intern
next
cell
wash
acid
buffer
ph
glycin
sodium
chlorid
inactiv
unintern
virion
cultur
rins
pb
fresh
media
appli
cell
incub
h
v
viru
replic
assembl
egress
assay
evalu
viru
replic
product
infecti
progeni
cell
cultur
infect
influenza
viru
h
residu
viru
wash
thrice
pb
medium
supplement
bbr
appli
cell
incub
h
cell
viabil
evalu
use
xtt
cell
viabil
assay
kit
biolog
industri
cromwel
ct
usa
accord
manufactur
instruct
cell
incub
bbr
h
atmospher
contain
incub
medium
discard
fresh
medium
ad
well
activ
xtt
solut
ad
sampl
incub
h
absorb
nm
measur
use
spectra
max
spectrophotomet
molecular
devic
san
jose
ca
usa
data
present
ratio
signal
examin
sampl
control
sampl
solventtr
cell
confoc
microscopi
analysi
cell
seed
coverslip
plate
tpp
trasadingen
switzerland
h
cell
wash
pb
infect
influenza
viru
presenc
bbr
incub
cell
wash
pb
fix
paraformaldehyd
permeabil
triton
incub
h
bovin
serum
albumin
bsa
contain
tween
poland
subsequ
cell
incub
h
mous
antinucleoprotein
antibodi
bei
resourc
manassa
va
usa
dilut
trisbuff
salin
tb
tween
buffer
cell
incub
h
alexa
fluor
goat
antimous
antibodi
molecular
probe
eugen
usa
dilut
trisbuff
salin
tb
tween
buffer
nuclear
dna
stain
dapi
poznan
poland
fluoresc
imag
acquir
use
zeiss
lsm
confoc
microscop
carl
zeiss
microscopi
gmbh
jena
germani
analyz
imagej
fiji
softwar
rel
amount
influenza
nucleoprotein
present
nuclei
assess
score
fluoresc
signal
viral
protein
overlap
nuclei
data
present
proport
fluoresc
intens
nuclei
total
cell
fluoresc
intens
distribut
valu
test
use
normal
test
equal
group
varianc
examin
test
statist
signific
calcul
use
test
dunn
multipl
comparison
test
p
valu
consid
signific
denot
asterisk
viral
rna
isol
use
viral
dnarna
isol
kit
biotechnolog
gdynia
poland
accord
manufactur
instruct
revers
transcript
carri
highcapac
cdna
revers
transcript
kit
appli
biosystem
waltham
usa
accord
manufactur
instruct
use
veriti
thermal
cycler
appli
biosystem
waltham
usa
whole
cdna
determin
quantit
realtim
pcr
qpcr
reaction
carri
touch
realtim
pcr
detect
system
biorad
hercul
ca
usa
min
min
follow
cycl
min
reaction
mixtur
contain
rt
hspcr
mix
probe
biotechnolog
gdynia
poland
specif
probe
label
fam
black
hole
quencher
sequenc
tca
ggc
ccc
ctc
aaa
gcc
nm
primer
specif
target
influenza
matrix
protein
nm
sens
primer
tga
gtc
ttc
taa
ccg
agg
antisens
primer
aaa
aac
atc
ttc
aag
tct
viral
cdna
reaction
mixtur
viru
copi
number
quantif
standard
dna
templat
known
copi
number
prepar
serial
dilut
standard
curv
prepar
describ
previous
lower
limit
detect
copiesml
nuclear
cytoplasm
fraction
isol
describ
briefli
cell
wash
pb
resuspend
hypoton
buffer
mm
tri
hcl
ph
mm
nacl
mm
glycerol
proteas
inhibitor
cocktail
roch
warsaw
poland
min
ad
reach
vv
concentr
sampl
incub
min
centrifug
g
cytoplasm
fraction
collect
nuclei
resuspend
nuclear
extract
buffer
b
mm
trishcl
ph
mm
nacl
mm
glycerol
min
ice
nuclei
subject
three
cycl
snapfreezethaw
insolubl
protein
remov
nuclear
extract
highspe
centrifug
obtain
fraction
mix
sampl
buffer
tri
ph
sd
mgml
dithiothreitol
dtt
boil
min
separ
polyacrylamid
gel
alongsid
dualcolor
pagerul
prestain
protein
size
marker
thermo
scientif
warsaw
poland
separ
protein
transfer
onto
westran
polyvinyliden
difluorid
pvdf
membran
whatman
maidston
uk
wet
blot
biorad
hercul
ca
usa
h
v
transfer
buffer
contain
mm
tri
mm
glycin
methanol
membran
block
overnight
incub
trisbuff
salin
tb
tween
buffer
ttb
supplement
skim
milk
bioshop
burlington
canada
membran
incub
h
mous
antinp
primari
antibodi
bei
resourc
manassa
va
usa
dilut
evalu
fraction
puriti
rabbit
antihiston
gapdhdilut
antibodi
thermo
scientif
warsaw
poland
use
suitabl
secondari
antibodi
label
horseradish
peroxidas
santa
cruz
biotechnolog
dalla
tx
usa
use
antibodi
dilut
tbstween
supplement
skim
milk
signal
develop
use
immobilon
western
chemiluminesc
hrp
horseradish
peroxidas
substrat
merck
millipor
warsaw
poland
visual
mp
imag
system
biorad
hercul
ca
usa
result
express
mean
standard
deviat
sd
halfmaxim
inhibitori
concentr
toxic
concentr
valu
calcul
use
graph
pad
prism
function
graphpad
softwar
san
diego
ca
usa
select
index
si
defin
ratio
determin
signific
result
obtain
student
ttest
use
p
valu
consid
signific
western
blot
analys
conduct
use
imag
lab
biorad
hercul
ca
usa
investig
antivir
activ
bbr
vitro
seri
cell
line
permiss
influenza
viru
infect
presenc
bbr
first
common
vitro
model
use
ie
cell
line
deriv
canin
kidney
cell
mdck
perform
standard
viru
replic
assay
infect
mdck
cell
presenc
absenc
bbr
concomitantli
cell
viabil
monitor
use
xtt
assay
signific
inhibitori
effect
bbr
mdck
cell
observ
experiment
set
sampl
treat
bbr
equal
observ
signific
decreas
cell
viabil
si
figur
tabl
result
indic
inhibitori
properti
similar
obtain
wu
et
al
conclud
bbr
hamper
replic
influenza
viru
mdck
cell
much
lesser
extent
vitro
model
next
human
pulmonari
tumor
cell
line
assay
inhibit
influenza
viru
bbr
cell
line
consist
report
mani
report
show
high
toxic
bbr
cancer
cell
includ
cell
line
therefor
bbr
propos
antineoplast
drug
candid
consid
bbr
cytotox
assay
cell
decid
verifi
antivir
bbr
activ
cell
result
indic
signific
decreas
influenza
replic
presenc
bbr
compound
cytotox
activ
concentr
si
figur
tabl
final
decid
test
immort
murin
lung
epitheli
type
cell
line
cell
line
noncancer
maintain
natur
signal
pathway
first
verifi
cytotox
bbr
cell
accept
next
test
effect
bbr
replic
influenza
viru
cell
rtqpcr
analysi
reveal
vast
decreas
viral
replic
nontox
concentr
si
figur
tabl
summar
test
three
differ
vitro
model
obtain
three
differ
result
sort
actual
activ
bbr
decid
evalu
bbr
natur
system
mimick
human
airway
epithelium
hae
briefli
hae
reconstitut
interfac
air
media
use
primari
human
cell
model
previous
wellcharacter
success
use
us
studi
best
knowledg
natur
cellular
model
test
potenti
inhibitori
compound
varieti
respiratori
virus
hae
cultur
form
welldifferenti
polar
cultur
resembl
vivo
pseudostratifi
mucociliari
epithelium
line
conduct
airway
human
respiratori
tract
observ
cytotox
test
concentr
ie
suggest
bbr
toxic
toward
noncancer
cell
consist
previous
publish
data
howev
bbr
inhibit
influenza
viru
replic
hae
cultur
higher
concentr
compar
cell
may
explain
fact
bbr
continu
present
cultur
daili
wash
apic
surfac
figur
taken
togeth
bbr
expect
inhibit
influenza
viru
natur
infect
care
taken
select
vitro
model
confirm
antiinfluenza
activ
bbr
next
step
determin
whether
bbr
affect
particular
stage
viru
replic
cycl
investig
made
seri
mechanist
experi
describ
earlier
work
assay
show
signific
decreas
influenza
viru
rna
copi
number
measur
rtqpcr
suggest
bbr
interfer
viru
viru
entri
traffick
genom
replic
figur
howev
observ
decreas
assay
v
suggest
bbr
affect
viru
assembl
matur
egress
figur
data
present
recent
publish
work
virus
suggest
bbr
act
cellular
pathway
essenti
effici
viru
replic
confirm
whether
bbr
inhibit
influenza
viru
downregul
mapkerk
pathway
confoc
imag
infect
cell
treat
two
differ
concentr
bbr
activ
concentr
specif
mapkerk
inhibitor
conduct
h
observ
characterist
accumul
viral
rnp
complex
insid
nuclei
cell
treat
bbr
figur
effect
confirm
imag
analysi
signific
differ
np
signal
accumul
observ
bbr
cell
compar
untreat
control
figur
np
coloc
nuclear
stain
cell
treat
bbr
compar
control
cell
effect
clearli
visibl
h
pi
time
larg
amount
rnp
also
visibl
cytoplasm
data
shown
outcom
may
due
remov
bbr
cell
degrad
western
blot
analys
indic
moder
inhibit
activ
bbr
concentr
inhibit
compar
cell
inhibit
figur
observ
howev
slight
increas
amount
phosphoerk
controlinfect
cell
previous
report
confirm
confoc
imag
result
perform
similar
experi
isol
cytoplasm
nuclear
fraction
western
blot
analysi
analysi
show
higher
quantiti
fold
increas
viral
np
nuclear
fraction
cell
treat
bbr
compar
untreat
infect
confirm
confoc
imag
observ
figur
lower
bbr
concentr
howev
caus
signific
accumul
influenza
viru
np
data
shown
case
cytoplasmat
fraction
observ
moder
yet
clear
decreas
np
inhibit
signal
treat
cell
may
suggest
bbr
interfer
assembl
releas
virion
take
result
togeth
obtain
data
suggest
inhibit
influenza
viru
bbr
downregul
pathway
influenza
viru
infect
among
major
public
health
threat
despit
mani
effort
list
approv
drug
short
emerg
resist
rapid
consequ
continu
need
new
broadspectrum
antiinfluenza
drug
mani
differ
sourc
drug
consid
natur
product
constitut
rich
librari
compound
may
use
identifi
new
structur
new
molecular
target
howev
knowledg
mechan
action
essenti
berberin
bbr
exhibit
number
biolog
activ
among
other
describ
potent
inhibitor
influenza
viru
work
undertook
comprehens
studi
antivir
properti
bbr
vitro
ex
vivo
also
delin
mechan
action
compound
report
antiinfluenza
properti
bbr
conflict
mdck
cell
cecil
et
al
show
bbr
affect
viru
replic
wu
et
al
report
substanti
inhibit
cultur
model
studi
observ
notic
influenza
viru
inhibitori
properti
high
concentr
similar
obtain
wu
et
al
main
differ
studi
concentr
rang
use
effect
concentr
mdck
cell
unusu
high
result
obtain
second
commonli
use
model
base
cell
also
slightli
confus
activ
bbr
report
cell
report
show
strong
cytotox
activ
bbr
toward
cancer
cell
includ
cell
inde
effect
concentr
rather
low
cytotox
concentr
also
low
imposs
determin
whether
observ
effect
artifact
sort
whether
antivir
effect
bbr
potenti
use
treatment
test
two
model
employ
noncancer
cell
origin
respiratori
cell
first
mous
immort
lung
epitheli
type
line
use
second
fulli
differenti
primari
human
airway
epithelium
hae
cultur
employ
case
observ
signific
antiinfluenza
properti
bbr
nontox
concentr
result
confirm
antiinfluenza
properti
bbr
low
toxic
compound
primari
cell
show
potenc
compound
inhibit
infect
tissu
subsequ
step
aim
understand
molecular
mechan
action
bbr
influenza
viru
function
assay
demonstr
effect
bbr
viru
replic
receptor
bind
viru
entri
celltypedepend
differ
compound
antivir
activ
suggest
compound
like
act
host
cell
viru
reason
made
effort
link
known
activ
bbr
pathway
import
replic
influenza
viru
two
recent
publish
report
show
bbrmediat
inhibit
chikungunya
viru
chikv
enteroviru
caus
interfer
virusinduc
mitogenactiv
protein
kinas
mapk
signal
pathway
includ
extracellular
signalrel
kinas
erk
also
known
activ
form
requir
nuclear
export
influenza
viru
rnp
complex
infect
pathway
modul
infect
first
erk
pathway
upregul
shortli
infect
rapidli
decreas
first
hour
next
pathway
upregul
late
stage
infect
rnp
must
export
nucleu
assembl
progeni
virion
erk
inhibit
specif
inhibitor
impair
rnp
transport
result
retent
rnp
insid
nucleu
consequ
inhibit
viral
replic
verifi
bbr
exhibit
activ
similar
confoc
microscopi
reveal
similar
rnp
retent
within
cell
nuclei
bbrtreat
mapkerk
inhibitor
cell
figur
accumul
nucleoprotein
also
observ
nuclear
fraction
cell
treat
bbr
analyz
figur
literatur
link
specif
mapkerk
inhibit
activ
bbr
cell
suggest
antivir
effect
specif
studi
use
bbr
dilut
dmso
solvent
conveni
use
cell
cultur
regulatori
agenc
recommend
topic
use
consid
rout
administr
antiinfluenza
drug
oral
inhal
intraven
solvent
consid
may
includ
conjug
nanocag
new
formul
may
also
increas
bioavail
bbr
summar
result
demonstr
inhibit
influenza
viru
bbr
nontox
concentr
antivir
effect
differ
cell
line
confirm
relev
use
advanc
model
human
respiratori
epithelium
subsequ
studi
reveal
inhibit
influenza
viru
replic
result
bbrspecif
inhibit
pathway
requir
effect
product
progeni
virion
worth
note
due
mechan
action
emerg
resist
mutant
less
like
commonli
use
inhibitor
target
viral
protein
